Advertisement

Topics

Lytix Biopharma AS Company Profile

15:44 EST 24th November 2017 | BioPortfolio

Lytix Biopharma AS develops novel drugs for treatment of resistant bacterial and fungal infections, as well as first-in-class oncology treatments. The Company was established in 2003 to commercialise world-class research in the field of lytic peptides spun out by the founding scientists working at the University of Tromsø and University Hospital in Norway. Operating out of Tromsø and Oslo and through a continued collaboration with the University of Tromsø the Company has access to state-of-the-art laboratories and staff with extensive experience of drug discovery research. Business and product development is driven from the subsidiary office in Oslo.


News Articles [1443 Associated News Articles listed on BioPortfolio]

KBI Biopharma: How to stand out in the CMO space

KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challe...

#jobs #lifescience Head of Quality Assurance, Biopharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Head of Quality Assurance, Biopharma .MA-Boston, Based in the Greater Boston ...

Propanc Biopharma Provides Shareholder Update for PRP on Current and Future Activities Leading ...

MELBOURNE, AUSTRALIA--(Marketwired - August 30, 2017) -Propanc Biopharma Inc.( OTCQB : PPCB) ("Propanc Biopharma" or "the Company"), a clinical stage biopharmaceutical Read more...

Vitality Biopharma to Present at The MoneyShow San Francisco Conference

LOS ANGELES, CA -- (Marketwired) -- 08/23/17 -- Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoi...

Vitality Biopharma Closes $1 Million Private Placement

LOS ANGELES, CA -- (Marketwired) -- 08/02/17 -- Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality", "Vitality Biopharma", or the "Company") a corporation dedicated to the development of cannabinoi...

CTI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference

SEATTLE, Aug. 31, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that management will present at the 24th Annual BioCentury NewsMakers in the Biot...

Critical Survey: Galena Biopharma (GALE) vs. Its Peers

Galena Biopharma is one of 116 publicly-traded companies in the "Pharmaceuticals" industry, but how does it compare to its peers? We will compare Galena Biopharma to similar companies based on the str...

#jobs #lifescience Senior Regulatory Affairs Manager – Biotech/Biopharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Senior Regulatory Affairs Manager – Biotech/Biopharma .CA-South San Fra...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Cardene® sr [PDL BioPharma, Inc.]

CARDENE® SR

Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [Baxter Healthcare Corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.

The production of active pharmaceutical ingredients (APIs) is currently undergoing its biggest transformation in a century. The changes are based on the rapid and dramatic introduction of protein- and...

On-line prediction of the glucose concentration of CHO cell cultivations by NIR and Raman spectroscopy: Comparative scalability test with a shake flask model system.

In this study, near-infrared (NIR) and Raman spectroscopy were compared in parallel to predict the glucose concentration of Chinese hamster ovary cell cultivations. A shake flask model system was used...

Multiplexing N-Glycan analysis by DNA analyzer.

Analysis of N-glycan structures has been gaining attentions over the years due to their critical importance to biopharma based applications and growing roles in biological research. Glycan profiling i...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes

ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and ...

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Companies [125 Associated Companies listed on BioPortfolio]

Lytix Biopharma

Lytix Biopharma AS

Lytix Biopharma AS develops novel drugs for treatment of resistant bacterial and fungal infections, as well as first-in-class oncology treatments. The Company was established in 2...

SAFE-BioPharma Association

SAFE-BioPharma Association (www.safe-biopharma.org) is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the ...

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-b...

TenX Biopharma, Inc.

TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...

More Information about "Lytix Biopharma AS" on BioPortfolio

We have published hundreds of Lytix Biopharma AS news stories on BioPortfolio along with dozens of Lytix Biopharma AS Clinical Trials and PubMed Articles about Lytix Biopharma AS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lytix Biopharma AS Companies in our database. You can also find out about relevant Lytix Biopharma AS Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record